ArticleRheumatology and therapy2022

A Randomised Controlled Trial Comparing the Pharmacokinetics and Tolerability of the Proposed Adalimumab Biosimilar MSB11022 Delivered via Autoinjector and Pre-filled Syringe in Healthy Subjects.

Ahad Sabet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.